https://www.moneycontrol.com/news/business/ipo/mankind-pharma-ipo-shares-trade-with-single-digit-premium-in-grey-market-10439601.html
0
0
35 words
0
Comments
Mankind Pharma is focused largely on the domestic market, which contributed to 97.60 percent to its revenue from operations for FY22.
You are the first to view
Create an account or login to join the discussion